Arthrosi Therapeutics doses first patient in replicate pivotal phase 3 REDUCE 1 trial of lead compound AR882: San Diego Wednesday, March 19, 2025, 11:00 Hrs [IST] Arthrosi Therape ...
Enlivex to receive Chinese patent for use of Allocetra as a potential treatment in patients with osteoarthritis: Nes-Ziona, Israel Wednesday, March 19, 2025, 10:00 Hrs [IST] Enliv ...
Glasgow, Scotland Wednesday, March 19, 2025, 09:00 Hrs [IST] ...
Nandita Vijayasimha, Bengaluru Wednesday, March 19, 2025, 08:00 Hrs [IST] ...
Exporters raise alarm over new Export NOC guidelines, seek urgent resolution: Shardul Nautiyal, Mumbai Wednesday, March 19, 2025, 08:00 Hrs [IST] Pharmaceutical exporters have rai ...
Parliamentary Panel calls for setting up of a platform CTMS for Ayush clinical research: Gireesh Babu, New Delhi Wednesday, March 19, 2025, 08:00 Hrs [IST] The Parliamentary Panel ...
Karnataka govt initiates several measures to address shortage of essential medicines: Nandita Vijayasimha, Bengaluru Wednesday, March 19, 2025, 08:00 Hrs [IST] Karnataka governmen ...
After initiating steps to recall all batches of counterfeit medicines from the supply chain, the West Bengal Drug Control Administration (WB DCA) has now started to closely monitor the discount ...
AstraZeneca’s Imfinzi (durvalumab) has been approved in the European Union (EU) as monotherapy for the treatment of adults with limited-stage small cell lung cancer (LS-SCLC) whose disease has not ...
Supriya Lifescience powers ahead with a New 5 MWp solar facility: Our Bureau, Mumbai Tuesday, March 18, 2025, 17:15 Hrs [IST] Supriya Lifescience Ltd., a cGMP-compliant company wi ...
China NMPA approves Akeso's penpulimab for first-line treatment of nasopharyngeal cancer: Hong Kong Tuesday, March 18, 2025, 17:00 Hrs [IST] Akeso Inc., a biopharmaceutical compan ...
PCRM reports swapping animal products for plant-based foods leads weight Loss: Our Bureau, Bengaluru Tuesday, March 18, 2025, 16:40 Hrs [IST] Replacing animal products with plant- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results